Method of treating psoriasis using an IL-17 receptor antibody formulation
Abstract:
The present disclosure relates to ΛM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
Public/Granted literature
Information query
Patent Agency Ranking
0/0